Chinese medicinal composition for treating scleroderma

The invention provides a Chinese medicinal composition for treating scleroderma. The Chinese medicinal composition comprises the following components in part by weight: 12 to 18 parts of honeysuckle flower, 9 to 15 parts of weeping forsythia, 5 to 7 parts of platycodon root, 9 to 15 parts of great b...

Full description

Saved in:
Bibliographic Details
Main Author XIE PEIDE
Format Patent
LanguageChinese
English
Published 19.09.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention provides a Chinese medicinal composition for treating scleroderma. The Chinese medicinal composition comprises the following components in part by weight: 12 to 18 parts of honeysuckle flower, 9 to 15 parts of weeping forsythia, 5 to 7 parts of platycodon root, 9 to 15 parts of great burdock achene, 12 to 18 parts of rehmannia root, 9 to 15 parts of figwort, 12 to 18 parts of red paeony root, 9 to 15 parts of tree peony root-bark, 12 to 18 parts of sinkiang arnebia root, 12 to 18 parts of hypericum japonicum, 28 to 32 parts of Japanese honeysuckle stem and 28 to 32 parts of coix seed. Compared with the prior art, the Chinese medicinal composition is used for treating scleroderma aiming at internal pathogenic factors according to differentiation of symptoms, is quick in curative effect, low in cost and obvious in effect, does not have toxic or side effect, and addresses both the symptoms and root causes.
Bibliography:Application Number: CN20121136340